Health Financing - Publications - Faculty & Research - Harvard Business School

Filter Results: (793)

Filter Results: (793)

Show Results For

← Page 30 of 793 Results →

Sort by

Are you looking for?

→Search All HBS Web

September 2006 (Revised February 2007)
Case

Timing of Option Grants at UnitedHealth Group (A)

Faced with press allegations that executives' stock options might have been backdated, the Board of UnitedHealth Group needs to determine whether its accounting for the options was proper, and if not, what the restatement amount should be and what... View Details

Keywords: Governing and Advisory Boards; Ethics; Stock Options; Accounting; Crisis Management; Corporate Governance; Health Industry; Health Industry; United States

September 2008 (Revised June 2013)
Case

Odyssey Healthcare

By: Robert F. Higgins, Virginia Fuller and Umer Raffat

In January 2001, Dick Burnham, CEO of Odyssey Healthcare, and Odyssey's Board of Directors were considering selling the hospice care company to a larger provider or making an initial public offering (IPO). With 38 hospice locations in 21 states, Odyssey had been... View Details

Keywords: Liquidity; Venture Creation/development; Hospice; Venture Capital; Financial Liquidity; Business Exit or Shutdown; Business Growth and Maturation; Business Plan; Entrepreneurship; Health Industry; United States

October 2020
Case

Fiscal Responses to COVID-19

By: Rawi Abdelal, Rafael Di Tella, Vincent Pons and Galit Goldstein

For the first half of 2020, the COVID-19 crisis seemed on the verge of spiraling out of control. The business world struggled to figure out what COVID meant for macroeconomics. Extended restrictions limiting human interaction meant an end to normal economic production,... View Details

Keywords: Fiscal Policy; COVID; COVID-19; Economic Analysis; Economic Downturn; Economic Conditions; Economic Governance; Economic Systems; Economy; Health Pandemics; Finance; Policy; United States; Germany; France; European Union

Article

Achieving Value in Highly Complex Acute Care: Lessons from the Delivery of Extra Corporeal Life Support

By: Michael Nurok, Jonathan Warsh, Erik Dong, Jeffrey Lopez, Mayumi Kharabi and Robert S. Kaplan

We applied a value (outcomes and cost) analysis to extracorporeal life support (ECLS), a relatively rare but very expensive ICU therapy with highly variable outcomes. To address the outcome component of the value approach, we created guidelines for ECLS delivery; to... View Details

Keywords: Health Care and Treatment; Cost Management; Value; Analysis

July 2019
Article

Evaluation of Economic and Clinical Outcomes Under Centers for Medicare & Medicaid Services Mandatory Bundled Payments for Joint Replacements

By: Derek A. Haas, Xiaoran Zhang, Robert S. Kaplan and Zirui Song

In 2016, the Centers for Medicare & Medicaid Services (CMS) launched its first mandatory bundled payment program, the Comprehensive Care for Joint Replacement (CJR) model, by randomizing metropolitan statistical areas (MSAs) into the payment model. The paper analyzed... View Details

Keywords: Medicare; Medicaid; Bundled Payments; Health Care and Treatment; Cost Management; Performance Evaluation; Outcome or Result

Find at Harvard

Register to Read

24 Jul 2013
Op-Ed

Detroit Files for Bankruptcy: HBS Faculty Weigh In

and new construction. On the other hand, well-managed public-private partnerships, where the private sector funds, builds, and operates key public infrastructure, can shift the capital requirement from municipalities to the private sector. When there are adequate... View Details

Keywords: by John Macomber, Robert C. Pozen, Eric D. Werker & Benjamin Kennedy; Auto

February 27, 1994
Article

Innovation: Medicine's Best Cost-Cutter

By: M. E. Porter, Elizabeth Teisberg and Gregory Brown

Keywords: Innovation and Invention; Health; Cost

Find at Harvard

2020
Working Paper

Aggregate and Firm-Level Stock Returns During Pandemics, in Real Time

By: Laura Alfaro, Anusha Chari, Andrew Greenland and Peter K. Schott

We show that unexpected changes in the trajectory of COVID-19 infections predict U.S. stock returns, in real time. Parameter estimates indicate that an unanticipated doubling (halving) of projected infections forecasts next-day decreases (increases) in aggregate U.S.... View Details

Keywords: COVID-19; Stock Returns; Health Pandemics; Stocks; Investment Return; Forecasting and Prediction

September 2009 (Revised September 2010)
Case

Avid Radiopharmaceuticals and Lighthouse Capital Partners

By: Matthew Rhodes-Kropf and Ann Leamon

In fall 2008, a venture lender must decide whether to make a loan to Avid, a small but promising venture-backed life sciences firm. In reviewing her proposal, Cristy Barnes considers the company's characteristics and how they differ from a typical investment. At the... View Details

Keywords: Business Startups; Decision Choices and Conditions; Financial Crisis; Venture Capital; Private Equity; Financing and Loans; Investment; Health Industry; Health Industry

October 2010 (Revised July 2011)
Case

PrimedicProviding Primary Care in Mexico

By: Richard G. Hamermesh, Regina Garcia-Cuellar and Lauren Sarah Margulies

Primedic is a Mexican start-up that aims to deliver affordable primary and preventative healthcare to those at the base of the economic pyramid. The company is about to exhaust its first round of venture capital funding and the business model has yet to gain traction.... View Details

Keywords: Business Model; Business Startups; Developing Countries and Economies; Social Entrepreneurship; Venture Capital; Health Care and Treatment; Social Enterprise; Health Industry; Mexico

March 2024 (Revised July 2024)
Case

AMC: The Zero Revenue Case

By: C. Fritz Foley and Donal O'Cofaigh

The onset of the Covid-19 pandemic put theatre company AMC’s already perilous financial situation under even further strain. The company’s high levels of debt resulted in a monthly cash-burn which left it facing an imminent Chapter-11 filing in the absence of... View Details

Keywords: Ethics; Insolvency and Bankruptcy; Public Equity; Stock Shares; Health Pandemics; Entertainment and Recreation Industry

October 2023
Article

What Does the Inflation Reduction Act Mean for Patients and Physicians?

By: Amitabh Chandra and Benedic Ippolito

The debate around prescription drug measures in the recently passed U.S. Inflation Reduction Act (IRA), which limit some patients’ out-of-pocket costs, has not fully addressed their effect on physicians and patients via their effect on payers. Reducing patients’ costs... View Details

Keywords: Government Legislation; Price; Health Care and Treatment

Find at Harvard

January 2022 (Revised August 2022)
Case

Hello Heart: The Next Generation of Chronic Disease Management Apps

By: Ariel D. Stern and Danielle Golan

Hello Heart, a hypertension management app debated whether to go deep and cover other heart conditions, or to expand its solution to other chronic conditions. View Details

24 Mar 2002
Research & Ideas

Are Assets Only for America’s Wealthy?

enough money to prosper, low-income families' access to health benefits, their civic participation, family stability, and mental wellbeing are all diminished by their low success rate in building assets. Peter Tufano, Sylvan C. Coleman... View Details

Keywords: by Carla Tishler

May 1999 (Revised September 2003)
Case

Advanced Inhalation Research, Inc.

This case presents a look at the early start-up phase and development of Advanced Inhalation Research (AIR), a company engaged in the development of a new drug-delivery technology. Focuses on the risks, the steps taken to manage it, and the manner in which the company... View Details

Keywords: Technological Innovation; Risk Management; Valuation; Financing and Loans; Health Care and Treatment; Acquisition; Business Startups; Medical Devices and Supplies Industry

15 Mar 2011
First Look

First Look: March 15

tax policy. Teams and Team Effectiveness in Health Services Organizations Authors:Bruce J. Fried, Sharon Topping, and Amy C. Edmondson Publication:In Health Care Management: Organization Design and Behavior.... View Details

Keywords: Sean Silverthorne

08 Jun 2010
First Look

First Look: June 8

http://www.hbs.edu/research/pdf/10-102.pdf Does Diversification Create Value in the Presence of External Financing Constraints? Evidence from the 2008-2009 Financial Crisis Authors:Venkat Kuppuswamy and Belén Villalonga Abstract We... View Details

Keywords: Martha Lagace

November 2020 (Revised April 2021)
Case

Roll-Ups and Surprise Billing: Collisions at the Intersection of Private Equity and Patient Care

By: Trevor Fetter and Kira Seiger

This case describes the increasing investment by private equity (PE) firms in patient care and other healthcare services. The case focuses on investments in physician staffing firms and roll-up strategy investments in physician practice management (PPM). Included in... View Details

09 Jul 2001
Research & Ideas

Does Misery Love Companies? How Social Performance Pays Off

micrograms of total suspended particulates per cubic meter, yet the World Health Organization establishes 90 as a maximum safe level (Berlin's level is 50). Over 25,000 square kilometers of land were deforested in Brazil each year from... View Details

Keywords: by Joshua D. Margolis & James P. Walsh

May 2021
Article

Value-Based Healthcare in Urology: A Collaborative Review

By: Chanan Reitblat, Paul A. Bain, Michael E. Porter, David N. Bernstein, Thomas W. Feeley, Markus Graefen, Santosh Iyer, Matthew J. Resnick, C.J. Stimson, Quoc-Dien Trinh and Boris Gershman

Context:
In response to growing concerns over rising costs and major variation in quality, improving value for patients has been proposed as a fundamentally new strategy for how healthcare should be delivered, measured, and... View Details

Keywords: Value-based Healthcare; Integrated Practice Units; Outcome Measurement; Time-Driven Activity-Based Costing; Health Care and Treatment; Value; Cost Management; Strategy; Outcome or Result; Measurement and Metrics

Find at Harvard

←
30
31
…
39
40
→